Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to falsely low glucose readings.
Tandem Diabetes Care (NASDAQ:TNDM) reported record fourth-quarter and full-year 2025 results while outlining a major shift in ...
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the ...
Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the Blood Glucose Monitoring Devices Market is projected to grow from USD 16,202.5 ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Good day, and thank you ...
Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE).
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
As the connection between diabetes and cognitive decline becomes increasingly evident, it’s clear that managing blood glucose ...
In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...
Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the Blood Glucose Monitoring Devices ...
Stocktwits on MSN
Why did TNDM stock jump 5% after hours despite Q4 earnings miss?
The company's Q4 revenue of $290.4 million beat estimates, while U.S. revenue reached $210.5 million. ・Tandem guided to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results